1
/
of
1
Elabscience
SKU:PKSH032995
Recombinant Human RBP7 Protein
Recombinant Human RBP7 Protein
Regular price
$200.00 USD
Regular price
Sale price
$200.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Human RBP7 Protein, a highly purified and biologically active protein that has been produced using advanced recombinant DNA technology. This protein is a member of the retinol-binding protein family and is essential for the transport of retinol (vitamin A) in the blood.
The Recombinant Human RBP7 Protein is a high-quality product that has been extensively tested for purity, activity, and stability. It is suitable for a wide range of applications, including research, diagnostics, and therapeutic development.
This protein is available in a variety of sizes and formats to meet your specific needs. It is supplied as a lyophilized powder that can be easily reconstituted in water or buffer. The Recombinant Human RBP7 Protein is also available in bulk quantities for large-scale applications.
In summary, the Recombinant Human RBP7 Protein is a reliable and versatile product that can be used in a variety of applications. Its high purity, activity, and stability make it an ideal choice for researchers, clinicians, and biotech companies alike.
The Recombinant Human RBP7 Protein is a high-quality product that has been extensively tested for purity, activity, and stability. It is suitable for a wide range of applications, including research, diagnostics, and therapeutic development.
This protein is available in a variety of sizes and formats to meet your specific needs. It is supplied as a lyophilized powder that can be easily reconstituted in water or buffer. The Recombinant Human RBP7 Protein is also available in bulk quantities for large-scale applications.
In summary, the Recombinant Human RBP7 Protein is a reliable and versatile product that can be used in a variety of applications. Its high purity, activity, and stability make it an ideal choice for researchers, clinicians, and biotech companies alike.
Share
